|
Volume 272, Number 32,
Issue of August 8, 1997
pp. 20125-20130
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Parathyroid Hormone-dependent Degradation of Type
II Na+/Pi Cotransporters*
(Received for publication, September 12, 1996, and in revised form, February 28, 1997)
Markus F.
Pfister
,
Eleanor
Lederer
§,
Judith
Forgo
,
Urs
Ziegler
¶,
Marius
Lötscher
,
Elgar S.
Quabius
,
Jürg
Biber
 and
Heini
Murer
From the Institute of Physiology and ¶ Anatomy,
University of Zurich, CH-8057 Zurich, Switzerland and the
§ Department of Medicine, Division of Nephrology, University
of Louisville, Louisville, Kentucky 40292
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENT
REFERENCES
ABSTRACT
Parathyroid hormone (PTH) inhibits proximal
tubular brush border membrane Na+/Pi
cotransport activity; this decrease in the transport activity was found
to be associated with a decrease in type II
Na+/Pi cotransporter protein content in rat
brush border membranes. In the present study we investigated the
PTH-dependent regulation of the type II
Na+/Pi cotransporter in opossum kidney cells, a
previously established model to study cellular mechanisms involved in
the regulation of proximal tubular Na+/Pi
cotransport. We transfected opossum kidney cells with a cDNA coding
for NaPi-2 (rat renal type II
Na+/Pi cotransporter). This allowed the study
of PTH-dependent regulation of the transfected
NaPi-2 and of the corresponding intrinsic cotransporter (NaPi-4). The results show (i) that the intrinsic and the
transfected cotransporters are functionally (transport) and
morphologically (immunofluorescence) localized at the apical membrane,
(ii) that the intrinsic as well as the transfected
Na+/Pi cotransport activities are inhibited by
PTH, (iii) that PTH leads to a retrieval of both cotransporters from
the apical membrane, (iv) that both cotransporters are rapidly degraded
in response to PTH, and (v) that the reappearance/recovery of type II
Na+/Pi cotransporter protein and function from
PTH inhibition requires de novo protein synthesis. These
results document that PTH leads to a removal of type II
Na+/Pi cotransporters from the apical membrane
and to their subsequent degradation.
INTRODUCTION
Renal proximal tubular Pi reabsorption is acutely
regulated by parathyroid hormone
(PTH).1 This effect involves
inhibition of the brush border membrane sodium-dependent
Pi transport and is characterized by a decrease in the
maximal transport rate (Vmax) (1, 2). Two
different renal Na+/Pi cotransporters have been
cloned, classified either as type I Na+/Pi
cotransporter or as type II Na+/Pi
cotransporter (3-14). Both are localized at the brush border membrane
in proximal tubules. Recent data documented that physiologically and
pathophysiologically altered brush border membrane
Na+/Pi cotransport involves altered brush
border expression of the type II Na+/Pi
cotransporter (15-17).
In the present study we investigated the PTH-mediated regulation of the
type II Na+/Pi cotransporter in opossum cells
(OK cells); these cells have recently been shown to contain such a
cotransporter (NaPi-4; Ref. 8). The validity of the opossum
kidney cell model to study proximal tubular
Na+/Pi cotransport and its regulation has been
established (18-23). With respect to PTH-dependent control
of Na+/Pi cotransport activity, we have
reported that the recovery from the PTH-mediated inhibition of
Na+/Pi cotransport in OK cells is dependent on
de novo protein synthesis. This latter observation led to
the hypothesis that PTH might lead to the retrieval and degradation of
the transporter (27).
The aims of the present study were 2-fold: (i) to study
cellular/molecular mechanisms involved in PTH-dependent
control of type II Na+/Pi cotransporters, (ii)
to create by transfection an in vitro model that also
permits the study of the PTH control of the rat type II
Na+/Pi cotransporter. Obviously, the latter
approach would then offer a tool to characterize the molecular
determinants involved in such regulations. A prerequisite for this
approach was the availability of antisera, permitting a distinction
between intrinsic (NaPi-4) and transfected
(NaPi-2) cotransporters.
The results obtained show that both intrinsic (NaPi-4) and
transfected type II Na+/Pi cotransporters
(NaPi-2, rat) are functionally (transport) and
morphologically (immunofluorescence) located at the apical cell
surface, are functionally inhibited in response to PTH addition, are
retrieved in a PTH-dependent manner from the apical cell
surface (immunofluorescence), and are subsequently degraded (Western
blots). These data document that PTH control of the type II
Na+/Pi cotransporters involves a step of
membrane retrieval and degradation. Furthermore, the OK cell system
should represent the ideal in vitro model to dissect the
cellular/molecular mechanisms participating in regulation of this
proximal tubular transport function, which is crucially involved in
overall Pi homeostasis.
EXPERIMENTAL PROCEDURES
Vectors
The generation of the vectors used (pLKneo and
NaPi-2/pLKneo) has been described previously (24, 25). Both
vectors code for a geneticin (G418) resistance under a SV40 promoter.
In addition, the vector NaPi-2/pLKneo contains a cDNA
coding for the rat renal type II Na+/Pi
cotransporter (NaPi-2) under a dexamethasone-inducible
promoter.
Cell Cultures and Transfections
All cell culture supplies
were obtained from Life Technologies, Inc. (Basel, Switzerland).
Opossum kidney cells (clone 3B/2) were maintained in Dulbecco's
modified Eagle's medium/Ham's F-12 medium (1:1) supplemented with
10% fetal calf serum, 22 mM NaHCO3, 20 mM Hepes, 2 mM L-glutamine, 50 IU/ml penicillin, and 50 µg/ml streptomycin in a humidified
atmosphere of 5% CO2, 95% air at 37 °C.
Monolayers on permeable filter supports were grown on Millicell-CM
filter inserts (Millipore; 12-mm diameter, 0.45-µm pore size) coated
with a very thin film of rat tail collagen (R type, 0.5 mg/ml in 50%
ethanol; Serva, Basel, Switzerland). Cells were seeded at approximately
1-2 × 105 cells/filter and were re-fed with fresh
medium every 12 h until reaching confluency 24 h after
seeding. Transport studies were commenced 36 h after seeding. The
tightness of confluent cell monolayers has been measured by resistance
measurements as described previously (22).
For transfection, cells grown to a confluency of approximately 60% in
35 mm dishes (Nunc) were incubated for 16 h with 20 µl of a 1:1
mixture of water and Lipofectin (Life Technologies) containing 10 µg
of either NaPi-2/pLKneo or the same amount of empty vector
pLKneo. Afterward, cells were trypsinized, split at a ratio of 1:30,
and grown in 150-mm dishes (Nunc) in medium containing, in addition,
400 µg/ml active geneticin. After 1-2 weeks, colonies of
geneticin-resistant cells were isolated by ring cloning, expanded, and
analyzed for the expression of the NaPi-2 protein by
immunoblotting (see below). For experimental purposes, transfected
cells were used within 10 passages. Dexamethasone induction was
performed by an incubation with 1 µM dexamethasone (Sigma) for 20 h (10,000-fold stock, made in ethanol).
SDS-Polyacrylamide Gel Electrophoresis and
Immunoblotting
Cells grown to confluency in 10-cm Petri dishes
were incubated either with or without dexamethasone (1 µM) for 20 h and washed twice with TBS (0.9% NaCl,
10 mM Tris-HCl, pH 7.4). 15 ml of TBS containing 4 mM EDTA and 1 mM phenylmethylsulfonyl fluoride
was added, and the cells were scraped off the dish. The scraped cells were homogenized 5 times with a 20-ml syringe connected to a 20-gauge needle. This homogenate was centrifuged at 2000 rpm for 10 min at
4 °C (Sorvall centrifuge, SS-34 rotor). The postnuclear supernatant was centrifuged at 16,000 rpm for 40 min at 4 °C (Sorvall
centrifuge, SS-34 rotor). The pellet corresponding to a crude membrane
preparation was resuspended in 100 µl of 50 mM mannitol,
10 mM Hepes-Tris (pH 7.2).
In experiments in which the PTH-mediated degradation of the
Na+/Pi cotransporter was investigated, the
total cell homogenate was centrifuged at 31,000 rpm (100,000 g) for 60 min at 4 °C (Sorvall ultracentrifuge OTD 50B/T865 rotor) to ensure
that all membranes were contained within the pellet. The pellet was
resuspended in 200 µl of 50 mM mannitol, 10 mM Hepes-Tris (pH 7.2). The protein concentration was
determined by the Bio-Rad protein assay. 50 µg of total protein were
used for SDS-polyacrylamide gel electrophoresis (9%) and subsequent
transfer to nitrocellulose (Schleicher & Schuell, Inc.; 0.45 µm).
Nonspecific binding was blocked by incubating the nitrocellulose at
room temperature for 2 h in TBS (0.9% NaCl, 10 mM
Tris-HCl, pH 7.4) containing 5% nonfat dry milk and 1% Triton X-100
(Blotto-TX-100, pH 7.4). The transfected NaPi-2 protein was
detected using a polyclonal antiserum raised against the N terminus of
the NaPi-2 protein (14) (antibody dilution, 1/4000). The
intrinsic NaPi-4 protein was detected using a polyclonal
antiserum raised against the C-terminal 12 amino acids of the published NaPi-4 sequence (8) (antibody dilution, 1/2000). Incubation with the primary antibody took place overnight at 4 °C. The
nitrocellulose was washed four times with TBS, 10% Blotto-TX-100 (pH
7.4) and incubated for 1 h with Blotto-TX-100 (pH 7.4) at room
temperature. Then the nitrocellulose was incubated with a 1:10,000
dilution of an anti-rabbit IgG labeled with horseradish peroxidase
(Amersham Life Science, Inc.) in Blotto-TX-100 (pH 7.4) for 2 h at
room temperature. The nitrocellulose was washed four times with TBS, and the signals were detected by enhanced chemiluminescense (Amersham) according to manufacturer protocol using Kodak X-Omat AR films. For
peptide protection assays, the corresponding antigenic peptide was
included at a concentration of 100 µg/ml. Broad range
SDS-polyacrylamide gel electrophoresis molecular mass marker proteins
(Bio-Rad) were run in parallel.
Immunofluorescence
NaPi-2-transfected and
untransfected 3B/2 OK cells were grown to confluency on coverslips as
well as on permeable filter supports, as described previously (22).
After washing three times with PBS containing 0.5 mM
MgCl2 and 1 mM CaCl2, cells were
fixed for 10 min at room temperature with PBS supplemented with 3%
paraformaldehyde, washed three times with PBS, incubated 10 min with 20 mM L-glycine in PBS, and washed again (3 times)
with PBS. Permeabilization was performed by an incubation for 30 min
with PBS containing 0.1% saponin (PBS/saponin). After one wash with
PBS/saponin, cells were incubated with anti-NaPi-2 (14) or
anti-NaPi-4 antiserum at a dilution of 1:100 in PBS/saponin
for 1 h at room temperature and washed three times with
PBS/saponin. Thereafter, the cells were incubated with a fluorescein
isothiocyanate-conjugated IgG (Dakopatts, Denmark) (dilution, 1:50) and
phalloidine rhodamine (Calbiochem) (dilution, 1:50) in PBS/saponin.
After incubation for 30 min in the dark, cells were washed three times
with PBS/saponin and once with PBS. Coverslips were mounted using
Dako-Glycergel (Dakopatts) plus 2.5% 1,4-diazabicyclo-[2.2.2]octane
(Sigma) as a fading retardant. Immunofluorescence was revealed by
confocal microscopy (Zeiss laser scan microscope 310; Zeiss,
Oberkochen, Germany).
Scanning Electron Microscopy
OK cell monolayers grown on
collagen-coated porous filter supports were prefixed with 0.25%
glutaraldehyde in 0.16 M cacodylate buffer (pH 7.2) for 30 min at room temperature, postfixed with 2% glutaraldehyde in 0.16 M cacodylate buffer also for 30 min at room temperature,
and washed three times with 0.16 M cacodylate buffer (pH
7.2) for 5-10 min. After that, the monolayers were osmicated with 1%
OsO4 in 0.16 M cacodylate buffer (pH 7.2) for 1 h at 37 °C, washed three times with 0.16 M
cacodylate buffer, dehydrated in an acetone series, and dried by the
critical point method. The specimens were then examined in a scanning
electron microscope 505 (Philips, Eindhoven).
Phosphate Uptake
Measurements
Na+-dependent and
-independent transport of phosphate was determined in cells grown to
confluency on either plastic dishes (35 mm; Nunc) or on permeant filter
supports (8 mm), as described previously (22). Briefly, uptake
solutions consisted of 137 mM NaCl, 5.4 mM KCl,
2.8 mM CaCl2, 1.2 mM
MgSO4, 10 mM Hepes-Tris (pH 7.4), and 0.1 mM KH232PO4 (1 µCi/ml). For Na+-independant uptake, NaCl was replaced
equimolarly by N-methyl-D-glucamine·HCl. Routine uptake on plastic dishes was performed at room temperature for
6 min and then stopped by washing the cells four times with ice-cold
stop solution (137 mM NaCl, 10 mM Tris-HCl, pH
7.2). Cells were solubilized with 1% Triton X-100, and radioactivity was determined by liquid scintillation. Transport rates are expressed as nmol of Pi taken up/mg of total cellular protein, which
was determined by the Bio-Rad protein assay.
For transport assays on permeant filter supports, growth medium was
aspirated, and both sides of the monolayer were gently rinsed twice in
substrate-free uptake solution. Filter insert monolayers were then
placed in a 24-well culture plate (Nunclon) for uptake measurements.
Substrate-free uptake solution (500 µl) was added to the appropriate
filter insert compartment, and
N-methyl-D-glucamine·HCl-uptake solution was
added to the opposite compartment. Transport was initiated by mixing 50 µl of the same uptake solution containing an 11-fold concentration of
the desired radioactive substrate to the uptake solution already
present in the filter insert compartment. Uptake was stopped as
described above. Nonspecific binding (blanks) was assessed measuring
zero time uptake in
N-methyl-D-glucamine·HCl-uptake solution by
starting uptake and immediately aspirating the uptake solution.
Nonspecific binding was <10% that of radioactivity associated with
any experimental point. Total radioactivity incorporated into the
monolayer was measured by liquid scintillation counting of the whole
filter insert.
PTH Incubation/Treatment with Cycloheximide
Incubation of
OK cells with PTH has been described previously (22). Treatment of OK
cells with cycloheximide to prevent protein synthesis has also been
described previously (27).
Presentation of the Results
Statistical results are
expressed as mean ± S.E. for three dishes. Significance was
accepted at p < 0.05. Experiments were repeated at
least twice, and one representative experiment was choosen for
presentation. The results presented concerning the transfected
NaPi-2 were obtained with one single clone of
NaPi-2-transfected 3B/2 OK cells. Qualitatively, the same
results were obtained with two other clones of stably
NaPi-2-transfected 3B/2 OK cells.
RESULTS
Characterization of OK Cells Stably Transfected with the Rat Renal
Type II Na+/Pi Cotransporter
(NaPi-2)
To study transport function, transfected OK
cells were grown to confluency on plastic Petri dishes and exposed to 1 µM dexamethasone for 20 h to induce the expression
of the transfected NaPi-2. As illustrated in Fig.
1, induction of NaPi-2
expression in transfected OK cells by dexamethasone led to an
approximately 2-fold stimulation of the
Na+-dependent Pi transport, whereas
dexamethasone had no significant effect on the
Na+/Pi cotransport activity in empty
vector-transfected and in untransfected OK cells. Furthermore,
dexamethasone had no effect in any of the tested cell lines on the
Na+-independent Pi transport (Fig. 1 and data
not shown). Corresponding experiments have been carried out with
NaPi-2-transfected OK cells grown to confluency on
collagen-coated porous filter supports. By measuring the Pi
transport at the apical and basolateral membrane separately in induced
and noninduced NaPi-2-transfected OK cells, it was found
that the additional Pi uptake, as observed in cells grown
on Petri dishes (Fig. 1), is entirely restricted to the apical membrane
(data not shown).
Fig. 1.
Dexamethasone-induced expression of
Na+/Pi cotransport in
NaPi-2-transfected OK cells. OK cells
(NaPi-2-transfected, empty vector-transfected, and
untransfected OK cells) were grown to confluency on plastic Petri
dishes and, where indicated (DEX, +), were exposed to 1 µM dexamethasone for 20 h. Dexamethasone-induced NaPi-2-transfected OK cells showed an approximately 2-fold
stimulation of the Na+/Pi cotransport activity,
whereas dexamethasone had no significant effect on the intrinsic
Na+/Pi cotransport in empty vector-transfected
and untransfected OK cells.
[View Larger Version of this Image (18K GIF file)]
Transfected OK cells were also analyzed for expression of the
NaPi-2 protein. Induction of NaPi-2-transfected
OK cells by dexamethasone (1 µM, 20 h) led to the
expression of a protein with an apparent molecular mass of 95-120 kDa
(Fig. 2). An excess of the corresponding
antigenic peptide (100 µg/ml) prevented the appearance of this band
completely. The band seen above the NaPi-2 protein is
unspecific: it is neither induced by dexamethasone nor protected by the
antigenic peptide (Fig. 2A). The intrinsic type II
transporter protein (NaPi-4) was detected by the use of an
antiserum directed against the C terminus of NaPi-4. Fig.
2B shows the NaPi-4-specific signal detected
with membranes obtained from untransfected OK cells. Specificity of the
anti-NaPi-4 antiserum was established by peptide protection
assay with the corresponding antigenic peptide (100 µg/ml; Fig.
2B). Comparing Fig. 2A with Fig. 2B
shows that the intrinsic NaPi-4 and the transfected
NaPi-2 have approximately the same molecular mass (95-120
kDa). Furthermore it is seen that the anti-NaPi-2 antiserum
does not cross-react with the intrinsic NaPi-4 (Fig.
2A, transfected cells in the absence of dexamethasone).
Fig. 2.
Expression of the NaPi-2 protein
in transfected OK cells, and expression of the intrinsic
NaPi-4 protein in untransfected OK cells.
NaPi-2-transfected (A) and untransfected OK
cells (B) were grown to confluency on Petri dishes and,
where indicated (DEX, +), were treated with dexamethasone (1 µM, 20 h). Crude membrane preparations were analyzed
by immunoblotting using an anti-NaPi-2 antiserum
(A) or an anti-NaPi-4 antiserum (B).
Incubation with primary antibody was performed in the absence
(Peptide, ) or in the presence (Peptide, +) of
the corresponding antigenic peptide (peptide protection). The staining
seen above the 116-kDa region in the Fig. 2A is unspecific
(see text).
[View Larger Version of this Image (26K GIF file)]
Expression of the type II transporter was also analyzed by
immunofluorescence. Immunofluorescence pictures obtained by confocal microscopy showed that both the intrinsic NaPi-4 (Fig.
3A) and the transfected
NaPi-2 (Fig. 3B) are localized at the apical
membrane within distinct clusters of a diameter of about 1-2 µm,
whereas no type II Na+/Pi
cotransporter-specific staining was seen at the basolateral membrane.
The immunohistochemical staining of the transfected NaPi-2
as well as of the intrinsic NaPi-4 could be specifically abolished by the corresponding antigenic peptide (100 µg/ml; data not
shown). In Figs. 3A and 3B, the parallel staining
for -actin (a component of the microvillar cytoskeleton) is shown.
It is apparent that NaPi-4-specific (Fig. 3A)
and NaPi-2-specific (Fig. 3B) staining on the
apical cell surface coincides with the -actin staining. In addition
to the above apical staining, -actin is also present at the
basolateral cell surfaces (Fig. 3A and 3B). Visualization of the apical surface of OK cells by scanning electron microscopy showed that microvilli are expressed at the apical surface,
forming distinct clusters (Fig. 3C); the diameter of the
clusters corresponds well with the diameter of the clusters seen by
immunofluorescence double staining for -actin and the corresponding
type II Na+/Pi cotransporter. Therefore the
data given in Fig. 3 (A-C) documents that intrinsic and
transfected type II Na+/Pi cotransporters are
predominantly expressed at the apical cell surface (most likely within
microvilli).
Fig. 3.
The intrinsic NaPi-4 protein and
the transfected NaPi-2 protein are expressed at the apical
membrane of OK cells within microvilli.
NaPi-2-transfected and untransfected OK cells were grown to
confluency on glass coverslips and further processed for
immunofluorescence (A and B). Each set of
pictures obtained by confocal microscopy contains an apically located
focal plane (xy-plane) and cross-sections corresponding to
xz and yz planes. White lines in the xy plane indicate the
different sections along the z axis. White lines
in the xz and yz planes indicate the location of the xy plane.
A and B show immunohistochemical double stainings of -actin and NaPi-4 in untransfected OK cells
(A) and -actin and NaPi-2 in
dexamethasone-induced NaPi-2-transfected OK cells (B). It is seen that -actin and NaPi-4 and
-actin and NaPi-2 colocalize within distinct clusters at
the apical membrane. Scanning electron microscopy demonstrates the
presence of clustered microvilli at the apical surface of OK cells
(C). The diameter of these clustered microvilli corresponds
well with the diameter of the distinct clusters at the apical membrane
seen in the immunofluorescence pictures in Fig. 3, A and
B.
[View Larger Version of this Image (73K GIF file)]
PTH-dependent Regulation of Type II
Na+/Pi Cotransporters
Fig.
4 summarizes the effect of PTH
(10 8 M; 4 h) on the
Na+-dependent Pi transport in
NaPi-2-transfected OK cells as well as in untransfected OK
cells. PTH inhibited the Na+-dependent
Pi transport activity in control cells by about 60%. A
similar inhibitory effect of PTH was observed in
NaPi-2-transfected cells that were not treated with
dexamethasone. In cells expressing the NaPi-2 transporter
(induced by dexamethasone), PTH also inhibited the additionally
expressed Na+/Pi cotransport activity.
Interestingly, the residual transport activity after PTH treatment was
similar in all cells tested. This latter observation is in agreement
with earlier studies (21, 27) demonstrating a PTH-insensitive
Na+/Pi cotransport activity in OK cells.
Fig. 4.
Parathyroid hormone (10 8
M h) leads to the inhibition of the intrinsic and the
transfection-mediated Na+/Pi cotransport
activity in transfected OK cells. Na+/Pi
cotransport was determined in cells grown to confluency on Petri
dishes. Confluent NaPi-2-transfected and untransfected 3B/2 OK cells were treated with dexamethasone (DEX, 1 µM, 20 h) and/or PTH (10 8
M, 4 h), respectively, where indicated.
[View Larger Version of this Image (16K GIF file)]
The effect of PTH on the type II Na+/Pi
cotransporter protein content was investigated by immunoblotting. Fig.
5 shows that incubating OK cells for
increasing times with PTH (10 8 M) leads to a
time-dependent decrease of NaPi-4 and
NaPi-2 protein expressed in OK cells. We conclude that the
whole protein was degraded due to PTH action and that both transfected
(NaPi-2) and intrinsic transporter (NaPi-4)
behave very similar, i.e. are degraded. The finding that PTH
leads to the degradation of the type II Na+/Pi
cotransporter is in agreement with our previous observation that the
recovery of the Na+/Pi cotransport after
PTH-mediated inhibition is dependent on de novo protein
synthesis (27, 28). To evaluate whether the recovery of the transport
was due to de novo synthesis of type II
Na+/Pi cotransporter, cell monolayers were
exposed to 10 8 M PTH for 4 h, PTH was
removed, and cell monolayers were incubated with normal medium in the
presence or absence of 20 µM cycloheximide for 2 or
4 h. The results presented in Fig. 6
show that the reappearance of the transporter is dependent on de
novo protein synthesis. It is also seen that 4 h after PTH
removal, the reappearance of the transporter is not completed. Parallel
measurements of the Na+/Pi cotransport showed
that after 4 h of PTH removal, the recovery of the
Na+/Pi cotransport is also incomplete. This is
in agreement with our previous observation that complete recovery of
Na+/Pi cotransport from PTH inhibition takes
about 10-12 h (28).
Fig. 5.
Parathyroid hormone (10 8
M) leads to the disappearance of the
NaPi-4-specific (A) and
NaPi-2-specific (B) staining on
immunoblots. Untransfected and NaPi-2-transfected OK
cells were grown to confluency on Petri dishes, and
NaPi-2-transfected OK cells were induced by dexamethasone
(1 µM, 20 h). OK cells were treated with PTH (10 8 M) for various lengths of time (0, 1, 2, and 4h) and analyzed by immunoblotting for the expression of
NaPi-4- and NaPi-2 proteins.
[View Larger Version of this Image (56K GIF file)]
Fig. 6.
Reappearance of the NaPi-4
protein after PTH removal requires de novo protein
synthesis. Confluent OK cell monolayers were incubated for 4 h with PTH (10 8 M). Then the culture medium
was removed, cells were repeatedly washed with normal medium to remove
the PTH, and cells then incubated with medium with or without 20 µM cycloheximide for 2 and 4 h, respectively. The
above Western blot shows clearly that the reappearance of the
transporter is dependent on de novo protein synthesis.
[View Larger Version of this Image (17K GIF file)]
The retrieval of the intrinsic (NaPi-4) and the transfected
cotransporter (NaPi-2) upon addition of PTH could also be
documented by immunofluorescence. Consistent with the data presented
above (Figs. 4, 5, 6), we found that incubating OK cells with PTH
(10 8 M) leads to a time-dependent
decrease of NaPi-4-dependent immunofluorescence and NaPi-2-dependent immunofluorescence at the
apical membrane of OK cells (data not shown). After 4 h of PTH
treatment (10 8 M), the
Na+/Pi cotransporter type II-specific
immunofluorescence staining in untransfected (Fig.
7A) and
NaPi-2-transfected OK cells (Fig. 7B) was
virtually absent. Corresponding immunofluorescence pictures (double
immunofluorescence) stained for -actin clearly showed that under
these conditions the microvilli were still present at the apical
surface of OK cells. With the aim to detect the retrieved
Na+/Pi cotransporters within intracellular
vesicles, we have treated OK cells for increasing times with PTH (0, 0.5, 1, 2, and 4 h; data not shown). As mentioned above, we
observed a time-dependent decrease of the
NaPi-4-specific staining and NaPi-2-specific
staining at the apical surface. However, we were not able to detect a
significant amount of NaPi-4 protein or NaPi-2
protein within intracellular vesicles at any time points (data not
shown). As already suggested by the experiments presented in Fig. 5, a
delay between a PTH-dependent membrane retrieval and
intracellular degradation seems to be absent or minimal.
Fig. 7.
Parathyroid hormone (10 8
M, 4 h) leads to the disappearance of the
NaPi-2- and NaPi-4-specific immunohistochemical
staining within the microvilli at the apical membrane.
Untransfected and NaPi-2-transfected OK cells were grown to
confluency on glass coverslips. NaPi-2-transfected OK cells
were induced by dexamethasone (1 µM, 20 h), and
untransfected and induced transfected OK cells were treated with PTH
(10 8 M, 4 h) where indicated. Each set
of pictures obtained by confocal microscopy contains an apically
located focal plane (xy-plane) and cross-sections
corresponding to xz and yz planes. White lines in the xy
plane indicate the different sections along the z axis, whereas the white lines in the xz and yz planes indicate the
location of the xy plane. It is seen that after 4 h of PTH
treatment, the NaPi-4-specific (A) and
NaPi-2-specific (B) staining within the microvilli has almost completely disappeared, whereas the microvilli are still present at the apical membrane (see -actin
stainings).
[View Larger Version of this Image (42K GIF file)]
DISCUSSION
Previous studies on rats have suggested that inhibition of
Na+/Pi cotransport in renal proximal tubules by
PTH involves a retrieval of the type II Na+/Pi
cotransporter (NaPi-2) from the brush border membrane (15). The recent cloning of the type II Na+/Pi
cotransporter of OK cells (NaPi-4; Ref. 8) and the obvious limitations of an in vivo system to study molecular
mechanisms prompted us to investigate the regulation of this
transporter by PTH in OK cells. OK cells are a renal epithelial cell
line that has been used successfully to investigate mechanisms involved in the control of proximal tubular Na+/Pi
cotransport by PTH (21, 27). In the present study, we stably
transfected OK cells with a cDNA coding for the rat type II
Na+/Pi cotransporter (NaPi-2) and
investigated whether similar mechanisms are involved in the
PTH-mediated regulation of the intrinsic (NaPi-4) and the
transfected transporters (NaPi-2).
On immunoblots, appearance of the transfected (NaPi-2) and
the intrinsic (NaPi-4) cotransporter proteins resembled
each other closely. The broad staining pattern (95-120 kDa) of these
transporters likely represents different degrees of glycosylation,
which for the NaPi-2 protein, has recently been
demonstrated (29). The expression of the rat type II
Na+/Pi cotransporter was also demonstrated by
transport experiments. Dexamethasone-induced
NaPi-2-transfected OK cells exhibited an approximately
2-fold-stimulated transport activity compared with uninduced
NaPi-2-transfected or control cells (untransfected
and empty vector-transfected). Immunofluorescence experiments
demonstrated an exclusive apical localization for both
Na+/Pi cotransporters (intrinsic and
transfected), that, in the case of the intrinsic NaPi-4, is
in agreement with earlier transport studies performed with OK cells
grown on permeant filter supports (22). Furthermore, immunofluorescence
demonstrated a concentration of the intrinsic as well as of the
transfected Na+/Pi cotransporters within
clustered microvillar structures. It is suggested that such a distinct
concentration of the Na+/Pi cotransporters
within the microvilli may be due to a yet unknown interaction of these
transporters with components of the microvillar cytoskeleton. Clearly
no immunostaining related to these transporters was detected in the
basolateral membrane, suggesting a specific apical sorting mechanism
for the type II Na+/Pi cotransporters in OK
cells. In contrast, we recently demonstrated that the
NaPi-2, when transfected into Madin-Darby canine kidney cells, is expressed to equal amounts at the apical and basolateral membrane (25). The observed different sorting behavior of the same
transporter in two different cell lines indicates that not only
molecular determinants are decisive for a polarized sorting but that
also the cellular context is of importance. This has also been
documented for other proteins and cell systems. For example, it has
been shown that aquaporin-2, when transfected into LLC-PK1
cells, is, upon cAMP stimulation, inserted into the basolateral
membrane rather than into the apical membrane as suggested from studies
on native renal epithelia (30).
In previous studies it has been demonstrated that the intrinsic apical
Na+/Pi cotransport activity in OK cells is
inhibited by PTH (21, 27). In the present study we extended this
observation by showing that the inhibition of the
Na+/Pi cotransport by PTH in OK cells is
paralleled by the disappearance of the apical,
Na+/Pi cotransporter-specific
immunofluorescence staining within the microvilli. It is also shown
that PTH leads to the degradation of the type II
Na+/Pi cotransporter in OK cells. This finding
is in agreement with our earlier observation demonstrating that the
recovery of Na+/Pi cotransport activity from
PTH inhibition in OK cells is dependent on de novo protein
synthesis. Correspondingly, we found that the recovery of
Na+/Pi cotransport activity from PTH inhibition
was paralleled on immunoblots by the reappearance of the type II
Na+/Pi cotransporter protein. In the presence
of cycloheximide, there was neither a recovery of transport activity
nor a reappearance of the specific transporter protein. As documented
by immunoblots and by immunohistochemical studies presented in this
paper, PTH leads to an almost complete retrieval and degradation of the
type II Na+/Pi cotransporter (Figs. 5 and 7).
However, even after prolonged exposures to PTH, a "refractory"
residual Na+/Pi cotransport activity is
observed (Fig. 4 and Ref. 21). This implies that this residual activity
(~40% of total transport activity) is not related to the type II
Na+/Pi cotransporter but could be associated
with, for example, the type I transporter. Such conclusions are also
valid for the Na+/Pi cotransport activity in
rat brush border membranes; 2 h of PTH treatment leads to a much
higher reduction of the NaPi-2 protein compared with the
reduction in Na+/Pi cotransport activity
(15).
The present study clearly indicates that the regulation of the type II
Na+/Pi cotransporter in renal proximal tubules
and in OK cells is very similar. One apparent difference exists: after
PTH treatment of OK cells for various lengths (0.5, 1, 2 , and 4 h) we were not able to detect a significant transient intracellular
staining specific for the type II Na+/Pi
cotransporter. In rat proximal tubules, the degradation of the
NaPi-2 protein seems to be delayed (compared with the OK
cell system), permitting a visualization of an increased intracellular NaPi-2 protein content after short (15 min to 1 h) but
not after prolonged treatments with PTH (15). Despite this difference, the similarities in the regulation of this transporter by PTH in OK
cells and in rat renal proximal tubules are evident. Furthermore, in
this report we demonstrated that the transfected (NaPi-2)
and intrinsic type II Na+/Pi cotransporters
(NaPi-4) are regulated in OK cells in the same way by PTH.
OK cells are therefore a physiologically relevant in vitro
system for the study of the regulation of the type II Na+/Pi cotransporter type II. They are a useful
tool to dissect the molecular/cellular mechanisms involved in the
PTH-mediated internalization and subsequent degradation of the
transporter. Although it is tempting to assume a final breakdown of
these Na+/Pi cotransporters within lysosomes,
the mechanisms involved in internalization, trafficking, and subsequent
degradation are completely unknown.
In summary, the present study shows (i) that the intrinsic
(NaPi-4) and the transfected rat type II
Na+/Pi cotransporter (NaPi-2) are
functionally and morphologically localized at the apical membrane, (ii)
that the intrinsic as well as the transfection-mediated
(NaPi-2) Na+/Pi cotransport
activities are inhibited by PTH, (iii) that PTH leads to the
disappearance of both cotransporters from the apical membrane, and (iv)
that both cotransporters are rapidly degraded in response to PTH. These
results suggest that PTH leads to the endocytosis of the type II
Na+/Pi cotransporters from the apical membrane
and to their subsequent degradation, thereby leading to the
down-regulation of the Na+/Pi cotransport.
FOOTNOTES
*
This work was supported by Swiss National Science Foundation
Grant 32.30785 (to H. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Institute of
Physiology, University Zürich-Irchel, Winterthurerstr. 190, CH-8057, Zürich, Switzerland. Tel.: 1 257 50 32; Fax:
01 257 57 15; E-mail: biber{at}physiol.unizh.ch.
1
The abbreviations used are: PTH, parathyroid
hormone; OK cells, opossum kidney cells; PBS phosphate-buffered saline;
neo, neomycin resistance-encoding gene; TBS, Tris-buffered
saline.
ACKNOWLEDGEMENT
We thank C. Gasser for professional assistance
in preparing the figures for this paper.
REFERENCES
-
Murer, H.
(1992)
J. Am. Soc. Nephrol.
2,
1649-1665
[Abstract]
-
Murer, H., and Biber, J.
(1992)
in
The Kidney: Physiology and Pathophysiology (Seldin, D. W., and Giebisch, G., eds), 2nd Ed., pp. 2481-2509, Raven Press, Ltd., New York
-
Chong, S. S., Kristjansson, K., Zoghbi, H. Y., and Hughes, M. R.
(1993)
Genomics
18,
355-359
[CrossRef][Medline]
[Order article via Infotrieve]
-
Collins, J. F., and Ghishan, F. K.
(1994)
FASEB J.
8,
862-868
[Abstract]
-
Hartmann, C., Wagner, C. A., Busch, A. E., Markovich, D., Biber, J., Lang, F., and Murer, H.
(1995)
Eur. J. Physiol.
430,
830-836
[CrossRef][Medline]
[Order article via Infotrieve]
-
Magagnin, S., Werner, A., Markovich, D., Sorribas, V., Stange, G., Biber, J., and Murer, H.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5979-5983
[Abstract/Free Full Text]
-
Miyamoto, K., Tatsumi, S., Sonoda, T., Yamamoto, H., Minami, H., Taketani, J., and Taheda, E.
(1995)
Biochem. J.
305,
81-85
-
Sorribas, V., Markovich, D., Hayes, G., Stange, G., Forgo, J., Biber, J., and Murer, H.
(1994)
J. Biol. Chem.
269,
6615-6621
[Abstract/Free Full Text]
-
Verri, T., Markovich, D., Perego, C., Norbis, F., Stange, G., Sorribas, V., Biber, J., and Murer, H.
(1995)
Am. J. Physiol.
268,
F626-F633
[Abstract/Free Full Text]
-
Werner, A., Moore, M. L., Mantei, N., Biber, J., Semenza, G., and Murer, H.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
9608-9612
[Abstract/Free Full Text]
-
Werner, A., Murer, H., and Kinne, R.
(1994)
Am. J. Physiol.
267,
F311-317
[Abstract/Free Full Text]
-
Murer, H., and Biber, J.
(1994)
Curr. Opin. Nephrol. Hypertens.
3,
504-510
[Medline]
[Order article via Infotrieve]
-
Biber, J., Custer, M., Werner, A., Kaissling, B., and Murer, H.
(1993)
Eur. J. Physiol.
424,
210-215
[CrossRef][Medline]
[Order article via Infotrieve]
-
Custer, M., Lötscher, M., Biber, J, Murer, H., and Kaissling, B.
(1994)
Am. J. Physiol.
266,
F767-F774
[Abstract/Free Full Text]
-
Kempson, S. A., Lötscher, M., Kaissling, B., Biber, J., Murer, H., and Levi, M.
(1995)
Am. J. Physiol.
268,
F784-F791
[Abstract/Free Full Text]
-
Levi, M., Lötscher, M., Sorribas, V., Custer, M., Arar, M., Kaissling, B., Murer, H., and Biber, J.
(1994)
Am. J. Physiol.
267,
F900-F908
[Abstract/Free Full Text]
-
Tenenhouse, H. S., Werner, A., Biber, J., Ma, S., Martel, J., Roy, S., and Murer, H.
(1994)
J. Clin. Invest.
93,
671-676
-
Biber, J., Forgo, J., and Murer, H.
(1988)
Am J. Physiol.
255,
C155-C161
[Abstract/Free Full Text]
-
Caverzasio, J., and Bonjour, J. P.
(1989)
Am. J. Physiol.
257,
F712-F717
[Abstract/Free Full Text]
-
Caverzasio, J., Rizzoli, R., and Bonjour, J. P.
(1986)
J. Biol. Chem.
261,
3233-3237
[Abstract/Free Full Text]
-
Reshkin, S. J., Forgo, J., and Murer, H.
(1990)
Eur. J. Physiol.
416,
624-631
[CrossRef][Medline]
[Order article via Infotrieve]
-
Reshkin, S. J., Forgo, J., and Murer, H.
(1990)
Eur. J. Physiol.
416,
554-560
[CrossRef][Medline]
[Order article via Infotrieve]
-
Reshkin, S. J., Forgo, J., Biber, J., and Murer, H.
(1991)
Eur. J. Physiol.
419,
256-262
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hirt, R. P., Poulain-Godefroy, O., Billotte, J., Krähenbühl, J. P., and Fasel, N.
(1992)
Gene
111,
199-206
[CrossRef][Medline]
[Order article via Infotrieve]
-
Quabius, E. S., Murer, H., and Biber, J.
(1996)
Am. J. Physiol.
270,
F220-F228
[Abstract/Free Full Text]
-
Deleted in proofDeleted in proof
-
Malmstrom, K., and Murer, H.
(1987)
FEBS Lett.
216,
257-260
[CrossRef][Medline]
[Order article via Infotrieve]
-
Quamme, G., Pfeilschifter, J., and Murer, H.
(1989)
Biochim. Biophys. Acta
1013,
159-165
[Medline]
[Order article via Infotrieve]
-
Hayes, G., Busch, A., Lötscher, M., Waldegger, S., Lang, F., Verrey, F. Biber, and Murer, J.
(1994)
J. Biol. Chem.
269,
24143-24149
[Abstract/Free Full Text]
-
Katsura, T., Verbavatz, J. M., Farinas, J., Ma, T., Ausiello, D. A., Verkman, A. S., et al.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
7212-7216
[Abstract/Free Full Text]
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Mahon
Ezrin promotes functional expression and parathyroid hormone-mediated regulation of the sodium-phosphate cotransporter 2a in LLC-PK1 cells
Am J Physiol Renal Physiol,
March 1, 2008;
294(3):
F667 - F675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Stratta, C. Canavese, M. Quaglia, E. Lazzarich, V. Morellini, M. Brustia, B. Bardone, and G. Bellomo
A patient with unexplained hyperphosphataemia
Nephrol. Dial. Transplant.,
September 1, 2006;
21(9):
2664 - 2666.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ristic, S. M. R. Camargo, E. Romeo, S. Bodoy, J. Bertran, M. Palacin, V. Makrides, E. M. Furrer, and F. Verrey
Neutral amino acid transport mediated by ortholog of imino acid transporter SIT1/SLC6A20 in opossum kidney cells
Am J Physiol Renal Physiol,
April 1, 2006;
290(4):
F880 - F887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Klapper, H. Daniel, and F. Doring
Cytosolic COOH terminus of the peptide transporter PEPT2 is involved in apical membrane localization of the protein
Am J Physiol Cell Physiol,
February 1, 2006;
290(2):
C472 - C483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Honegger, P. Capuano, C. Winter, D. Bacic, G. Stange, C. A. Wagner, J. Biber, H. Murer, and N. Hernando
Regulation of sodium-proton exchanger isoform 3 (NHE3) by PKA and exchange protein directly activated by cAMP (EPAC)
PNAS,
January 17, 2006;
103(3):
803 - 808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Berndt, S. Schiavi, and R. Kumar
"Phosphatonins" and the regulation of phosphorus homeostasis
Am J Physiol Renal Physiol,
December 1, 2005;
289(6):
F1170 - F1182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Berndt and R. Kumar
The Phosphatonins and the Regulation of Phosphorus Homeostasis
IBMS BoneKEy,
June 1, 2005;
2(6):
5 - 16.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xu, J. K. Uno, M. Inouye, J. F. Collins, and F. K. Ghishan
NF1 transcriptional factor(s) is required for basal promoter activation of the human intestinal NaPi-IIb cotransporter gene
Am J Physiol Gastrointest Liver Physiol,
February 1, 2005;
288(2):
G175 - G181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Mahon and G. V. Segre
Stimulation by Parathyroid Hormone of a NHERF-1-assembled Complex Consisting of the Parathyroid Hormone I Receptor, Phospholipase C{beta}, and Actin Increases Intracellular Calcium in Opossum Kidney Cells
J. Biol. Chem.,
May 28, 2004;
279(22):
23550 - 23558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Tenenhouse, C. Gauthier, H. Chau, and R. St.-Arnaud
1{alpha}-Hydroxylase gene ablation and Pi supplementation inhibit renal calcification in mice homozygous for the disrupted Npt2a gene
Am J Physiol Renal Physiol,
April 1, 2004;
286(4):
F675 - F681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Wang, C. Li, T.-H. Kwon, R. T. Miller, M. A. Knepper, J. Frokiaer, and S. Nielsen
Reduced expression of renal Na+ transporters in rats with PTH-induced hypercalcemia
Am J Physiol Renal Physiol,
March 1, 2004;
286(3):
F534 - F545.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. J. Mahon, J. A. Cole, E. D. Lederer, and G. V. Segre
Na+/H+ Exchanger-Regulatory Factor 1 Mediates Inhibition of Phosphate Transport by Parathyroid Hormone and Second Messengers by Acting at Multiple Sites in Opossum Kidney Cells
Mol. Endocrinol.,
November 1, 2003;
17(11):
2355 - 2364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pribanic, S. M. Gisler, D. Bacic, C. Madjdpour, N. Hernando, V. Sorribas, A. Gantenbein, J. Biber, and H. Murer
Interactions of MAP17 with the NaPi-IIa/PDZK1 protein complex in renal proximal tubular cells
Am J Physiol Renal Physiol,
October 1, 2003;
285(4):
F784 - F791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Moz, J. Silver, and T. Naveh-Many
Characterization of cis-acting element in renal NaPi-2 cotransporter mRNA that determines mRNA stability
Am J Physiol Renal Physiol,
April 1, 2003;
284(4):
F663 - F670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Khundmiri, M. J. Rane, and E. D. Lederer
Parathyroid Hormone Regulation of Type II Sodium-Phosphate Cotransporters Is Dependent on an A Kinase Anchoring Protein
J. Biol. Chem.,
March 14, 2003;
278(12):
10134 - 10141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hernando, N. Deliot, S. M. Gisler, E. Lederer, E. J. Weinman, J. Biber, and H. Murer
PDZ-domain interactions and apical expression of type IIa Na/Pi cotransporters
PNAS,
September 3, 2002;
99(18):
11957 - 11962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Cavet, S. Akhter, R. Murtazina, F. Sanchez de Medina, C.-M. Tse, and M. Donowitz
Half-lives of plasma membrane Na+/H+ exchangers NHE1-3: plasma membrane NHE2 has a rapid rate of degradation
Am J Physiol Cell Physiol,
December 1, 2001;
281(6):
C2039 - C2048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. HERNANDO, J. FORGO, J. BIBER, and H. MURER
PTH-Induced Downregulation of the Type IIa Na/Pi-Cotransporter Is Independent of Known Endocytic Motifs
J. Am. Soc. Nephrol.,
November 1, 2000;
11(11):
1961 - 1968.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Z. Karim-Jimenez, N. Hernando, J. Biber, and H. Murer
A dibasic motif involved in parathyroid hormone-induced down-regulation of the type IIa NaPi cotransporter
PNAS,
October 23, 2000;
(2000)
220394197.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Murer, N. Hernando, I. Forster, and J. Biber
Proximal Tubular Phosphate Reabsorption: Molecular Mechanisms
Physiol Rev,
October 1, 2000;
80(4):
1373 - 1409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Zhao and H. S. Tenenhouse
Npt2 Gene Disruption Confers Resistance to the Inhibitory Action of Parathyroid Hormone on Renal Sodium-Phosphate Cotransport
Endocrinology,
June 1, 2000;
141(6):
2159 - 2165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Traebert, H. Volkl, J. Biber, H. Murer, and B. Kaissling
Luminal and contraluminal action of 1-34 and 3-34 PTH peptides on renal type IIa Na-Pi cotransporter
Am J Physiol Renal Physiol,
May 1, 2000;
278(5):
F792 - F798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Karim-Jimenez, N. Hernando, J. Biber, and H. Murer
Requirement of a leucine residue for (apical) membrane expression of type IIb NaPi cotransporters
PNAS,
March 14, 2000;
97(6):
2916 - 2921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hernando, S. Sheikh, Z. Karim-Jimenez, H. Galliker, J. Forgo, J. Biber, and H. Murer
Asymmetrical targeting of type II Na-Pi cotransporters in renal and intestinal epithelial cell lines
Am J Physiol Renal Physiol,
March 1, 2000;
278(3):
F361 - F368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. LEDERER, S. S. SOHI, and K. R. MCLEISH
Parathyroid Hormone Stimulates Extracellular Signal-Regulated Kinase (ERK) Activity Through Two Independent Signal Transduction Pathways: Roleof ERK in Sodium-Phosphate Cotransport
J. Am. Soc. Nephrol.,
February 1, 2000;
11(2):
222 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Traebert, J. Roth, J. Biber, H. Murer, and B. Kaissling
Internalization of proximal tubular type II Na-Pi cotransporter by PTH: immunogold electron microscopy
Am J Physiol Renal Physiol,
January 1, 2000;
278(1):
F148 - F154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. S. Guner, P. R. Kiela, H. Xu, J. F. Collins, and F. K. Ghishan
Differential regulation of renal sodium-phosphate transporter by glucocorticoids during rat ontogeny
Am J Physiol Cell Physiol,
November 1, 1999;
277(5):
C884 - C890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Murer, I. Forster, N. Hernando, G. Lambert, M. Traebert, and J. Biber
Posttranscriptional regulation of the proximal tubule NaPi-II transporter in response to PTH and dietary Pi
Am J Physiol Renal Physiol,
November 1, 1999;
277(5):
F676 - F684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. TRAEBERT, M. LÖTSCHER, R. ASCHWANDEN, T. RITTHALER, J. BIBER, H. MURER, and B. KAISSLING
Distribution of the Sodium/Phosphate Transporter during Postnatal Ontogeny of the Rat Kidney
J. Am. Soc. Nephrol.,
July 1, 1999;
10(7):
1407 - 1415.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. C Forster, M. Traebert, M. Jankowski, G. Stange, J. Biber, and H. Murer
Protein kinase C activators induce membrane retrieval of type II Na+-phosphate cotransporters expressed in Xenopus oocytes
J. Physiol.,
June 1, 1999;
517(2):
327 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, J. M. Norian, C. E. Magyar, N.-H. Holstein-Rathlou, A. K. Mircheff, and A. A. McDonough
In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition
Am J Physiol Renal Physiol,
May 1, 1999;
276(5):
F711 - F719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Pfister, J. Forgo, U. Ziegler, J. Biber, and H. Murer
cAMP-dependent and -independent downregulation of type II Na-Pi cotransporters by PTH
Am J Physiol Renal Physiol,
May 1, 1999;
276(5):
F720 - F725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Jehle, H. Hilfiker, M. F. Pfister, J. Biber, E. Lederer, R. Krapf, and H. Murer
Type II Na-Pi cotransport is regulated transcriptionally by ambient bicarbonate/carbon dioxide tension in OK cells
Am J Physiol Renal Physiol,
January 1, 1999;
276(1):
F46 - F53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Lederer, S. S. Sohi, J. M. Mathiesen, and J. B. Klein
Regulation of expression of type II sodium-phosphate cotransporters by protein kinases A and C
Am J Physiol Renal Physiol,
August 1, 1998;
275(2):
F270 - F277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Pfister, I. Ruf, G. Stange, U. Ziegler, E. Lederer, J. Biber, and H. Murer
Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter
PNAS,
February 17, 1998;
95(4):
1909 - 1914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hilfiker, C. M. Hartmann, G. Stange, and H. Murer
Characterization of the 5'-flanking region of OK cell type II Na-Pi cotransporter gene
Am J Physiol Renal Physiol,
January 1, 1998;
274(1):
F197 - F204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Karim-Jimenez, N. Hernando, J. Biber, and H. Murer
A dibasic motif involved in parathyroid hormone-induced down-regulation of the type IIa NaPi cotransporter
PNAS,
November 7, 2000;
97(23):
12896 - 12901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Wang, T.-H. Kwon, C. Li, J. Frokiar, M. A. Knepper, and S. Nielsen
Reduced expression of Na-K-2Cl cotransporter in medullary TAL in vitamin D-induced hypercalcemia in rats
Am J Physiol Renal Physiol,
January 1, 2002;
282(1):
F34 - F44.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|